A vial can test 99% pure by HPLC and still be the wrong molecule. That happens whenever a deletion peptide, missing a single amino acid, elutes close enough to the target to hide inside the main peak. Purity and identity are two different questions, and one number on a certificate cannot answer both.
That distinction matters because purity is not a marketing figure, it is an experimental variable. It decides whether a viability curve, a cytokine panel or a binding assay means anything at all. An impure lot does not simply weaken an effect, it can manufacture one that was never there.
Where impurities come from
Solid-phase peptide synthesis builds a sequence one amino acid at a time, and every coupling step carries a small risk of not completing. Those failures accumulate across a sequence. Without thorough purification, a vial can contain the target peptide alongside truncated (deletion) peptides, insertion impurities, structural isomers, residual solvent and counter-ion salts. Material sourced without verification has been found to carry heavy metals, synthesis truncations and toxic levels of residual trifluoroacetate.
None of that is inert in a cell culture well. Contaminants at this level can produce unpredictable cytotoxicity, false-negative apoptosis readouts and badly skewed cytokine measurements, and the failure mode is rarely obvious from the data alone.
What HPLC actually measures
High-performance liquid chromatography separates the components of a sample and quantifies each one by peak area, typically using UV detection at the wavelength where the peptide bond absorbs. On a research-grade report, look for a single dominant peak against a flat baseline, representing monomeric purity above 99%.
Read a chromatogram in this order:
- Peak shape. The main peak should be sharp and symmetrical. Fronting, tailing or a shoulder points to a closely related substance rather than one clean species.
- Baseline. Clusters of small early or late peaks indicate synthesis byproducts, residual solvent or degradation.
- The integration table. The purity percentage on the front page should match the area percentages listed under the trace.
- Run conditions. Column, gradient, mobile phase and detection wavelength should all be stated. A chromatogram with no method block is an image, not a result.
Why mass spectrometry is the other half
HPLC tells you a sample is essentially one substance. It does not prove that substance is the peptide on the label, which is the gap electrospray ionisation mass spectrometry (ESI-MS) closes. It measures molecular weight, and the experimental mass has to match the theoretical mass calculated from the sequence.
This is where the deletion peptide from the opening becomes visible. It can hide inside a broad HPLC peak, but it cannot hide a mass deficit. For long or complex sequences, a GLP-1, GIP and glucagon tri-agonist for example, deletion and insertion impurities occur routinely during synthesis, and mass confirmation stops being optional.
| Parameter | HPLC | Mass spectrometry |
| Question answered | How pure is it? | Is it the right molecule? |
| Measures | Relative abundance by peak area | Molecular weight of the species present |
| Detects | Byproducts, isomers, degradation, aggregates | Deletion and insertion sequences, wrong compound entirely |
| Typical output | Chromatogram plus integration table | Spectrum with observed against theoretical mass |
| Blind spot | Co-eluting impurities of similar polarity | Says nothing about how much impurity is present |
A proper certificate carries both. A report with only one of the two leaves half the specification unproven.
Purity is not the same as peptide content
Chromatographic purity is the share of the peptide material that is the target sequence. Net peptide content is the share of the dry mass in the vial that is peptide at all. The rest is counter-ions, bound water and residual salts.
Peptides are usually isolated as trifluoroacetate or acetate salts, and that counter-ion carries real weight. A lyophilisate can be 99% pure by HPLC and still contain a meaningful fraction of non-peptide mass, which matters the moment a molar concentration is calculated for an assay. TFA is also biologically relevant on its own: residual trifluoroacetate is poorly tolerated by sensitive cell cultures, so removing it is part of proper downstream processing, not an optional extra.
A complete analysis quantifies moisture and confirms peptide content alongside the purity figure. Our published batch analytical documentation is built around exactly that separation.
Reading a Certificate of Analysis
Who ran the test
Reliable documentation comes from an accredited third-party analytical facility, ideally inside the EU, or from a certified academic laboratory. An in-house report from the manufacturing site is a self-assessment. It may well be accurate, but it is not independent evidence, and treating it as such is how failed experiments start.
Whether you can check it yourself
Reputable testing facilities print a unique code or QR code on every certificate. You enter that code on the laboratory's own portal and pull the authentic document straight from their server. A PDF with no way to verify it cannot be told apart from an edited one, which makes this the single most useful filter you have.
Whether the batch actually matches
The lot number on the vial in your hand has to match the batch number on both the HPLC and the mass spectrometry reports exactly. Check the test date as well: it should follow the synthesis date, and a certificate reused across several production runs is a certificate for none of them.
A working checklist
- Both HPLC and MS present, with legible axes and stated method conditions.
- Single dominant peak, purity figure consistent with the integration table.
- Observed mass matched against theoretical mass for the sequence.
- Peptide content and moisture reported separately from chromatographic purity.
- Third-party laboratory named, with a verification code or portal link.
- Batch and lot numbers aligned across vial, chromatogram and spectrum.
Storage matters just as much
Analytical rigour is wasted if the material degrades in transit. Lyophilised peptides are sensitive to extended heat exposure and to mechanical agitation, and a long intercontinental route supplies plenty of both. Sourcing from a supplier that holds physical stock inside the European Union avoids extended customs delays and keeps the cold chain intact between warehouse and bench.
Once the vial arrives, standard handling still applies: keep lyophilised material cold, dry and protected from light, let vials reach ambient temperature before opening so condensation does not reach the powder, and limit freeze-thaw cycles on reconstituted stock by aliquoting. Poor handling produces the same degradation peaks on a chromatogram as poor synthesis.
Why some vendors skip the testing
Independent European HPLC and ESI-MS analysis costs us over €200 per synthesis lot. We pay it on every lot, before bottling, so monomeric purity is confirmed above 99% by a laboratory with no commercial interest in the outcome. High-resolution mass spectrometry catches missing residues that routine screening overlooks, and precise moisture testing rules out excessive TFA or acetate salt residues. Every batch we release is independently tested, and we will always tell you exactly what documentation exists for your specific lot.
The reason so many suppliers omit this step is structural rather than scientific. Affiliate-driven shops carry marketing costs that can inflate shelf prices several times over, and the analytical budget is the easiest line to cut, since customers rarely audit a PDF. We would rather spend the money on instrument time than on commissions, which is why independent batch testing is standard across the Pepsup research catalogue.
All products supplied by Pepsup are for laboratory research use only. Not for human or veterinary consumption, and not for diagnostic or therapeutic use.